Abstract
Purpose
The purpose of this study is to examine whether epirubicin loaded DC Bead 300–500 μm in size can pass through a 1.8-Fr ultraselective microcatheter in ex vivo study.
Methods
Epirubicin (25 mg/1 mL) loaded 100–300 and 300–500 μm DC Bead were tested. Both sizes were diluted 5, 10, and 30 times using contrast material. Ultraselective microcatheter with the outer diameter of 1.8 Fr and the inner diameter of .017 inch (431.8 μm) was used. The diluted DC Bead was injected at a speed of 1 mL/min, and the pressure was continuously measured. The microspheres’ shapes after ejection were observed by a stereomicroscope.
Results
The maximum pressure of contrast material alone was 8.40 ± 0.21 psi. The maximum pressure in 5, 10, and 30 times dilution groups of 100–300 μm were 9.67 ± 1.18, 9.25 ± 0.25, and 9.71 ± 0.28 psi, respectively, whereas 21.10 ± 10.2, 10.48 ± 2.14, 10.09 ± 0.37 psi, respectively in 300–500 μm groups. The maximum pressure in 5 times dilution group of 300–500 μm was significantly higher than the other groups (P < 0.05). In 300–500 μm, 4 of 10 measurements showed high pressure over 24 psi (the maximum value was 43.5 psi) in 5 times dilution group, whereas in 10 times and 30 times dilution groups, all measurements showed less than 12 psi. No damages of microspheres were found.
Conclusions
Epirubicin loaded DC Bead 300–500 μm in size can pass through a 1.8-Fr ultraselective microcatheter. To avoid high resistance due to microspheres’ aggregation, dilution more than 10 times is needed.
References
Takaki S, Sakaguchi H, Anai H et al (2012) Long-term outcome of transcatheter subsegmental and segmental arterial chemoembolization using lipiodol for hepatocellular carcinoma. Cardiovasc Interv Radiol 35:544–554
Shimohira M, Ogino H, Kawai T et al (2011) Use of the triaxial microcatheter method in super-selective transcatheter arterial chemoembolisation for hepatocellular carcinoma. Br J Radiol 84:184–187
Lencioni R, De Baere T, Burrel B et al (2012) Transcatheter treatment of hepatocellular carcinoma with doxorubicin-loaded DC bead (DEBDOX): technical recommendations. Cardiovasc Interv Radiol 35:980–985
Lewis AL, Gonzalez MV, Leppard SW et al (2007) Doxorubicin eluting beads - 1: effects of drug loading on bead characteristics and drug distribution. J Mater Sci Mater Med 18:1691–1699
Lewis AL, Gonzalez MV, Lloyd AW et al (2006) DC bead: in vitro characterization of a drug-delivery device for transarterial chemoembolization. J Vasc Interv Radiol 17:335–342
Hidaka K, Nakamura M, Osuga K, Miyazaki H, Wada S (2010) Elastic characteristics of microspherical embolic agents used for vascular interventional radiology. J Mech Behav Biomed Mater 3:497–503
Tanaka T, Nishiofuku H, Maeda S et al (2014) Repeated bland-TAE using small microspheres injected via an implantable port-catheter system for liver metastases: an initial experience. Cardiovasc Interv Radiol 37:493–497
Acknowledgments
The authors acknowledge the advice of Ms. Marian Pahud (Valkenburg, The Netherlands) and Dr. Kuniyuki Hidaka (Department of Medical Technology, Osaka University Hospital, Osaka, Japan) in submitting this article. This research was partially supported by Tokai Medical Products, Kasugai, Japan.
Conflict of interest
Yasushi Fukuoka, Toshihiro Tanaka, Hideyuki Nishiofuku, Takeshi Sato, and Kimihiko Kichikawa have no conflict of interest and financial disclosures.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fukuoka, Y., Tanaka, T., Nishiofuku, H. et al. Compatibility of an Ultraselective Microcatheter and Epirubicin Loaded 300–500-μm DC Bead in Ex Vivo Study. Cardiovasc Intervent Radiol 38, 1284–1287 (2015). https://doi.org/10.1007/s00270-015-1057-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00270-015-1057-8